A	B	C	D	E	F	G	H	I	J	K	L	M	N	O	P	Q	R	S	T	U	V	W	X	Y	Z	AA	AB	AC	AD
1	Main
2								Q122	Q222	Q322	Q422	Q123	Q223	Q323	Q423
3		Yen (B)	3/31/2021	6/30/2021	9/30/2021	12/31/2021	3/31/2022	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2023		3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025	3/31/2026	3/31/2027	3/31/2028	3/31/2029	3/31/2030	3/31/2031	3/31/2032
4		Lixiana JP		22.9	21.9	25.6	22	25.1
5		Savaysa		0.5	0.5	0.4	0.5	0.6
6		Lixiana EU		23.4	23.7	27.2	22.6	28.6
7		Other		2.7	3.6	3.8	4.2	4.6
8		Edoxaban		49.5	49.699999999999996	57	49.300000000000004	58.900000000000006											205.6	244	259.4
9
10
11		Enhertu US		9.6	10.1	11.9	13.8	20											45.4	144.6	195.1
12		Enhertu EU		1.2	1.4	2.3	4.1	6.7
13		Enhertu JP		2.2	2.2	2.6	2.6	2.4
14		Enhertu Other		0	0	0	1.4	2.2
15		Enhertu		13	13.7	16.8	21.9	31.299999999999997											80.8	258.4
16
17		Turalio		0.6				0.8
18		Injectafer		14.9				14.1
19		Venofer		7.9				12.4
20		EU Lixiana		23.4				28.6
21		EU Nilemdo/Nustendi		0.7				1.3
22		EU Olmesartan		5.6				5.4
23		ASCA		26.5				31.9
24
25		Lixiana		22.9	21.9	25.6	22	25.1
26		Tarlige		7.1	7.1	8.7	7.3	8.9
27		Pralia		9.2	9.3	10.3	9.2	9.9
28		Efient		4.1	3.9	4.7	4	4.9
29		Tenelia		6.4	5.7	6.5	5.1	5.6
30		Vimpat		4.5	4.4	5.1	4.3	5.3
31		Ranmark		5.1	5	5.5	4.8	4.9
32		Canalia		4.3	4	4.7	3.8	4.1
33		Loxonin		5.8	5.5	6.3	4.6	4.6
34		Enhertu		2.2	2.2	2.6	2.6	2.4
35		Emgality		0.9	1.2	1.3	1.2	1.4
36		Espha		20	19.8	24.2	18.8	21
37		Vaccines		1.4	4	12.3	-2.9	0.5
38		Japan		129.1	126.5	138.1	95.8	109
39		HC		15.4	18.4	15.9	15	15.3
40
41		Revenue		264.069	265.9	281	233.9	280.317	327.48	300	300									1044.892	1278.478
42		COGS		85.228	87.4	90.6	84.8	74.798	84.769											353.4	363.525
43		Gross Profit		178.841	178.49999999999997	190.4	149.10000000000002	205.519	242.711	300										691.4920000000001	914.9530000000001
44		SG&A		81.258	84.5	90	96.4	96.373	113.486											362.456	471.221
45		R&D		54.038	55	60.1	85	74.931	75.723											260.326	341.57
46		Operating Expenses		135.296	139.5	150.1	181.4	171.304	189.209											622.782	812.7909999999999
47		Operating Income		43.545000000000016	38.99999999999997	40.30000000000001	-32.29999999999998	34.215	53.50200000000001											68.71000000000004	102.16200000000015
48		Interest Income		3.5190000000000006				-4.797999999999999												4.818	24.721
49		Pretax Income		47.064000000000014	38.99999999999997	40.30000000000001	-32.29999999999998	29.417000000000005												73.52800000000003	126.88300000000015
50		Taxes		11.842				10.563												6.543	17.7
51		Net Income		35.222000000000016	38.99999999999997	40.30000000000001	-32.29999999999998	18.854000000000006												66.98500000000003	109.18300000000015
52
53
54
55		Gross Margin		0.6772510215133166	0.6713050018804061	0.6775800711743772	0.6374519025224455	0.7331663794917896
56		Headcount						16739